Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Biologists at Brown University have discovered how a neuropeptide hormone made in the gut of flies can control their lifespan ...

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Weight loss drugs such as Wegovy have risen in popularity in recent months - but how exactly does it work and what are the side effects?

All of this means Lilly investors shouldn't panic. Even in the "worst case," Lilly's weight loss drugs have driven major revenue growth, and this is likely to continue -- whether compounders halt ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

Chitin also triggered increases in levels of glucagon-like peptide-1 (GLP-1), the hormone that Ozempic (semaglutide) and ...